Health-system pharmacists' role in improving immunization rates

American Journal of Health-System Pharmacy

Volumn 69, Issue 1, 2012, Pages 74-76

  Andrawis, Mary A ^a   Rehm, Susan J ^b,c  

^a CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c National Foundation for Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

GERIATRIC DISORDER; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFECTION RATE; INFLUENZA; INFLUENZA VACCINATION; INTERDISCIPLINARY COMMUNICATION; LEADERSHIP; NOTE; PHARMACIST; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RESPONSIBILITY; STAFF TRAINING;

EID: 84855278493     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110257     Document Type: Note

References (24)

1. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage among persons aged &γε;65 years and persons aged 18-64 years with diabetes or asthma. www.cdc.gov/ mmw r / p r e view/mmw r h tml / mm5343a2.htm (accessed 2011 Jan 12).
2. Centers for Disease Control and Prevention. Prevention and control of influenza. www. cd c . g ov /mmwr / p r e v i ew/ mmwrhtml/rr5306a1.htm (accessed 2011 Jan 12).
3. American Society of Health-System Pharmacists. Pharmacy Practice Model Initiative. www.ashp.org/PPMI.aspx (accessed 2011 Jan 12).
4. Centers for Disease Control and Prevention. Seasonal influenza. www.cdc.gov/ flu/about/qa/disease.htm (accessed 2011 Jan 12).
5. Centers for Disease Control and Prevention. Flu symptoms & severity. www. cdc . gov / f lu/about / d i s e a s e / symptoms.htm (accessed 2011 Oct 20).
6. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009; 9:601-10.
7. Tsai JC, Griffin MR, Nuorti JP et al. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis. 2008; 46:1664-72. (Pubitemid 351706762)
8. World Health Organization. 23-valent pneumococcal polysaccharide vaccine: WHO position paper. Wkly Epidemiol Rec. 2008; 83:373-84.
9. Atkinson W, Wolfe S, Hamborsky J et al., eds., Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. Chap 16. 11th ed. Washington, DC: Public Health Foundation; 2009.
10. Sanofi Pasteur. FDA licenses new influenza vaccine designed specifically for people 65 years of age and older. www.sanofipasteur.com/sanofi-pasteur2/ imageServlet?imageCode=27410& siteCode=SP-Corp (accessed 2011 Oct 26).
11. Centers for Disease Control and Prevention. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR. 2010; 59:1102-6.
12. Centers for Disease Control and Prevention. Use of standing orders programs to increase adult vaccination rates: recommendations of the Advisory Committee on Immunization Practices. www. cd c.gov/mmwr/preview/ mmwrhtml/rr4901a2.htm (accessed 2011 Jan 7).
13. Stone E, Morton S, Hulscher M et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med. 2002; 136:641-51. (Pubitemid 34462676)
14. American Society of Health-System Pharmacists. ASHP guidelines on the pharmacist's role in immunization. Am J Health-Syst Pharm. 2003; 60:1371-7.
15. Centers for Disease Control and Prevention. Strategies for increasing adult vaccination rates. www.cdc.gov/vaccines/recs/rate-strategies/adultstrat. htm (accessed 2011 Jan 7).
16. Crouse BJ, Nichol K, Peterson DC et al. Hospital-based strategies for improving influenza vaccination rates. J Fam Pract. 1994; 38:258-61. (Pubitemid 24093912)
17. Sokos DR, Skledar SJ, Ervin KA et al. Designing and implementing a hospitalbased vaccine standing orders program. Am J Health-Syst Pharm. 2007; 64:1096-1102. (Pubitemid 46801543)
18. Robke JL, Woods M. A decade of experience with an inpatient pneumococcal vaccination program. Am J Health-Syst Pharm. 2010; 67:148-52.
19. American Society of Health-System Pharmacists. ASHP guidelines on the pharmacist's role in immunization. www.ashp.org/DocLibrary/BestPractices/ SpecificGdlImmun.aspx (accessed 2011 Sep 26).
20. Maroyka EM, Andrawis M. Health care workers and influenza vaccination. Am J Health-Syst Pharm. 2010; 67:25. Editorial.
21. Talbot TR, Babcock H, Caplan AL et al. Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol. 2010; 31:987-95.
22. Van den Dool C, Bonten MJ, Hak E et al. Modeling the effects of influenza vaccination of healthcare workers in hospital departments. Vaccine. 2009; 27:6261-7.
23. Van den Dool C, Bonten MJ, Hak E et al. The effects of influenza vaccination of healthcare workers in nursing homes: insights from a mathematical model. PLoS Med. 2008; 5:e200.
24. Centers for Disease Control and Prevention. Influenza vaccination coverage estimates and selected related results from a national internet panel survey of health care personnel, United States, November 2010. www.cdc.gov/flu/pdf/vaccination/ BlackNovemberHCPsurveyResults.pdf (accessed 2011 Mar 29).